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1. Introduction 
Venoms are complex concentrates of biologically highly active molecules known as toxins, 
and they exist mainly as peptides and proteins. Several natural toxins are produced by 
plants, bacteria, phytoplanktonic dinoflagellates, sea anemones, insects, fungi and animals. 
In nature, toxins have two main functions: to capture their preferred prey (e.g. spiders, 
snakes, scorpions, etc.) or to serve as defence (e.g. bee sting, frog poison, etc.). Toxins 
produced by micro-organisms are important virulence factors. On the other hand they are 
also tools to combat diseases. Some of them are used in low quantities as drugs, to prepare 
vaccines and as important tools in biomedical research. Toxins affecting heart physiology 
are very effective in the sense of defence and especially in capturing prey. They can disturb 
electrical (producing arrhythmias) and mechanical activity of the heart affecting pumping or 
leading even to cardiac arrest. The aim of this chapter is to describe most of the toxins 
affecting heart function, their targets in the heart tissue, mode of action and the most 
important clinical effects of envenomation. 
2. Main molecular targets of the toxins in the heart 
2.1 Sodium channels 
Voltage-gated sodium channels are an essential part of excitable membranes and enable fast 
depolarisation, which is responsible for action potential (AP) generation in cardiomyocytes 
and in the some parts of the conduction system of the heart. Their density is very low in 
some parts of the heart's conductive system, e.g. sinoatrial node and atrioventricular node 
cells, and the highest in Purkinje cells and cardiomyocytes (Fozzard, 1996). Hence, they are 
targeted by several neurotoxins from plants and animals that use these molecules for 
defence and protection. 
2.2 Calcium channels 
Different types of Ca2+-permeable channels have been described in the plasma membrane of 
heart cells: the L- and T-type channels, both voltage activated, and a background channel 
(for a review see Carmeliet et al., 1999). Inward current through L-type high voltage-gated 
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calcium channels is responsible for prolonged AP in cardiac muscle cells and cardiac muscle 
contraction. L-type voltage-gated Ca2+-channels are especially target for some bacterial 
(saxitoxin) and animal toxins (atrotoxin, maitotoxin, -conotoxin, crotoxin). 
2.3 Potassium channels 
The role of potassium channels is to repolarize the membrane during the AP or to maintain 
hyperpolarizing potential. They are involved in the regulation of duration of the AP. 
Therefore, changes in the function of potassium channels may cause life-threatening 
arrhythmias (Carmeliet et al., 1999). Important potassium channels that can be the target of 
natural toxins are calcium-activated potassium channels (charybdotoxin, iberiotoxin, 
apamin) and voltage-gated potassium channels (some dendrotoxins). 
3. Biologically active molecules from different sources 
3.1 Biologically active molecules from plants 
3.1.1 Aconitine 
Aconitines are a group of very poisonous alkaloids derived from various aconite species. 
They are neurotoxins that open TTX-sensitive Na+ channels in the heart and other tissues 
(Wang & Wang, 2003). Some of them can bind to the high affinity receptor site 2 of sodium 
channels (Ki ~1.2 µM) and some of them to a low affinity binding site (Ki ~11.5 µM). The 
compounds of the high affinity group, which increases synaptosomal sodium and calcium 
activity (EC50 3 µM), are the most toxic and provoke tachyarrhythmia. Binding of aconitine 
to the site II of voltage-dependent Na+ channels prolongs the open state responsible for Na+ 
influx leading to the permanent depolarization. Now it is commonly accepted that aconitine 
produces arrhythmias by prolonging opening or delaying the inactivation of voltage-
dependent Na+ channels. Low affinity alkaloids from aconitum species are less-toxic, reduce 
intracellular calcium activity and induce bradycardia (Friese et al., 1997). 
3.1.2 Grayanotoxins 
At least four grayanotoxins (GTXs) have been isolated from the leaves of Rhododendron 
decorum (Ericaceae). These toxins are responsible for so called "mad honey" intoxication. 
Early in the 1980s it was published that GTXs produce cardiac tachyarrhythmias. The 
pathophysiological mechanism, underlying tachyarrhythmia, is the triggered activity in the 
form of oscillatory afterpotentials, as it was shown in feline cardiac Purkinje fibres (Brown et 
al., 1981). After intoxication, GTXs can produce bradyarrhythmias in man and livestock 
(Koca & Koca, 2007). It was shown that GTXs-induced cardiac toxicity in rats is a 
consequence of increased sodium channel permeability and activated vagus nerve (Onat et 
al., 1991). Intoxication is associated with the fatal bradyarrhythmias that include second 
degree atrio-ventricular block and circulatory collapse (Okuyan et al., 2010). 
3.1.3 Veratridine 
Veratrum species plants contain more than 200 different alkaloids, which are the principal 
toxins. The opening of voltage-gated sodium channels is probably one of the most relevant 
pathophysiological mechanisms of its toxicity. Veratridine injected intravenously in rats 
www.intechopen.com
Cardiovascular Pathophysiology Produced by 
Natural Toxins and Their Possible Therapeutic Implications 
 
3 
induced the Bezold-Jarisch-like effect (transient hypotension) accompanied by bradicardia 
(Chianca et al., 1985). It is well known that persistent sodium current, which can be 
enhanced during heart ischemia, is one of the major contributors to ischemic arrhythmias. 
Prolonged cardiac AP, which can also be induced by veratridine, favours the occurrence of 
early afterdepolarizations that is one of the pathophysiological mechanisms of 
tachyarrhythmias. Increased Na+ uptake activates the Na+/Ca2+ exchanger that leads to 
cardomyocytes’ Ca2+ overload. The latter can trigger the late depolarization after-potentials 
(DAPs), which is another pathophysiological mechanism underlying arrhythmias. If the 
amplitude of the DAPs reaches the threshold potential, a new AP is triggered. Such large, 
late DAPs often occur in the case of oscillations of the cytosolic Ca2+ concentration (Pignier 
et al., 2010). 
 
Name Source 
(produced 
by) 
Chemical 
structure 
Target Mode of 
action 
Effects Acute 
LD50 in 
mice 
Reference 
Cardiotoxic toxins from plants 
Aconitine Plants from 
genus 
Aconitum 
Alkaloid Voltage-
gated Na+ 
channels 
Depolariza-
tion, AP 
duration 
increase 
Arrhy-
thmias 
0.1 
mg/kg 
Gutser, 1998 
Grayanoto-
xins (GTX) 
Species from 
genus 
Rhododendron
Polyhydro-
xylated cyclic 
diterpene 
Increase Na+ 
channel 
permeability 
and activate  
vagus nerve 
Alteration of 
excitability 
Fatal 
cardiac 
bradyar-
rhythmias  
1.28 
mg/kg 
i.p. 
Brown et al., 
1981; 
Okuyan et 
al., 2010 ; 
Scott et al., 
1971 
Veratridine Plants in the 
family 
Liliaceae 
Steroid-
derived 
alkaloid 
Binding to 
the activated 
Na+ ion 
channels 
Depolariza-
tion, AP 
duration 
increase 
Arrhy-
thmias 
1.35 
mg/kg 
i.p. 
Chianca et 
al., 1985; 
Pignier et al., 
2010; Swiss 
& Bauer, 
1951 
Table 1. Natural cardiotoxic toxins from plants: source, structure, receptors, mode of action, 
effects on heart and toxicity. 
3.2 Cardiotoxic toxins derived from mushrooms 
3.2.1 Ostreolysin 
Ostreolysin (Oly) is an acidic, 15 kDa protein isolated from the edible oyster mushroom 
(Pleurotus ostreatus) (Berne et al., 2002). It is a toxic, pore-forming cytolysin (Sepčić et al., 
2003). When administered intravenously (i.v.), Oly causes electrocardiographic, arterial 
blood pressure and respiratory changes. Oly produces changes such as transient increase of 
arterial blood pressure followed by a progressive fall to mid-circulatory pressure 
accompanied by bradicardia, myocardial ischaemia and ventricular extrasystoles. Oly also 
induces lysis of rat erythrocytes in vitro and in vivo, resulting in hyperkalemia. Although 
direct action of the protein on the cardiomyocytes or heart circulation cannot be excluded 
(Oly is pore-forming toxin), the hyperkalemia resulting from the haemolytic activity seems 
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to play an important role in its cardiotoxicity (Žužek et al., 2006). Additionally, an important 
mechanism of the cardiotoxic effect may also be its concentration-dependent contractile 
effect on elastic blood vessels, such as aorta (Rebolj et al., 2009) and coronary vessels (Juntes 
et al., 2009). 
 
Name Source 
(produced by)
Chemical 
structure 
Target Mode of 
action 
Effects Acute 
LD50 in 
mice 
Refer-
ence 
Cardiotoxic toxins derived from mushrooms 
Ostreolysin Oyster 
mushroom 
(Pleurotus 
ostreatus) 
Pore-
forming 
protein 
Cell 
membranes
Pore 
formation
Bradycardia; 
myocardial 
ischaemia; 
ventricular 
extrasystoles, 
hyperkalemia
1.17 
mg/kg 
Žužek 
et al., 
2006 
Table 2. Natural cardiotoxic toxins from mushrooms: source, structure, receptors, mode of 
action, effects on heart and toxicity. 
3.3 Biologically active molecules produced by micro-organisms 
3.3.1 Bacterial toxins 
3.3.1.1 Vibrio parahemolyticus haemolysin (toxin) 
Vibrio parahemolyticus toxin is lethal for rats when injected i.v. in a dose of 5 g/kg or higher. 
It decreases intra-atrial and ventricular conductivity, and produces atrioventricular block. 
Before cardiac arrest occurs, ventricular flutter develops. The toxin is also toxic for 
cardiomyocytes in culture. Similar to the heart, the beating rhythm of cardiomyocytes 
exposed to the toxin increases and then abruptly stops (Honda et al., 1976).  
3.3.1.2 Streptolysin O 
Streptolisin O is a pore-forming toxin released in the extracellular medium by the majority 
of group A and some of group C and G Streptococci. It belongs to the sulphydryl- or thiol-
activated toxins. It is a protein with a molecular weight of about 67 kDa. Streprolysin O is 
capable of forming cation permeable pores in cholesterol-rich membranes. Administered i.v. 
in high doses it produces sudden cardiac arrest, probably due to a non-specific binding to 
the lipid bilayers of cardiac cells (for a review see Harvey, 1990).  
3.3.1.3 Saxitoxin 
Saxitoxin (STX) is produced by certain marine species of dinoflagellates (Alexandrium sp., 
Gymnodinium sp.) and cyanobacteria species (Anabaena sp., some Aphanizomenon spp., 
Cylindrospermopsis sp.). STX, usually administered through shellfish ingestion, is responsible 
for the human illness known as paralytic shellfish poisoning (PSP). STX acts primarily as a 
sodium channel blocker; it binds to the binding site 1 (Mebs & Hucho, 1990). Additionally it 
was found that STX also inhibits L-type Ca2+ currents in adult mouse ventricular myocytes 
(Su et al., 2003).  
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3.3.1.4 Tetrodotoxin 
Tetrodotoxin (TTX) is a toxin of microbial origin. A number of marine bacteria probably 
produce TTX, especially members of the genus Vibrio (most common species is Vibrio 
alginolyticus). The link between this species and production of TTX in animals has not been 
definitely confirmed as it is not clear whether the source of TTX in animals is the above-
mentioned bacteria. TTX has been isolated from many animal species (pufferfish, toads of 
the genus Atelopus, octopuses of the genus Hapalochlaena, etc. (Mebs & Hucho, 1990). It was 
shown that both high and low affinity receptors (sodium channels) for TTX exist on the rat 
cardiomyocytes. Only a low affinity binding site is functional on the cardiac cells, which has 
dissociation constant for TTX about three orders of magnitude higher compared to the 
reported dissociation constant for TTX receptors in muscle and nerve. The concentration 
needed to block cardiac sodium channels is very high (Renaud et al., 1983). The myocytes in 
the heart express fast voltage-gated sodium channel and therefore the generation of AP and  
 
Name Source 
(produced by) 
Chemical 
structure 
Target Mode of action Effects Acute 
LD50 in 
mice 
Reference 
Microbial toxins 
Bacterial toxins 
Hemolysin 
TDH, TRH 
Vibrio 
parahaemolyticus 
Protein Heart Alteration in 
conductance of 
the conductive 
system 
Arrhy-
thmias, 
cardiac arrest
Between 
2.5 and 5 
g/kg in 
rats 
Honda et 
al., 1976 
Streptolysin O Streptococci group 
A, C and G 
Protein Nonspecific 
binding 
(membranes 
rich on 
cholesterol) 
Pore formation Bradycardia, 
atrio-
ventricular 
conduction 
block 
8 g/kg 
i.v. 
Gill, 1982; 
Harvey, 
1990 
Tetrodotoxin 
(TTX) 
Bacteria: 
Pseudoalteromo-nas 
tetraodonis, certain 
species of 
Pseudomonas and 
Vibrio 
heterocyclic, 
organic, 
water-
soluble non-
protein 
molecule 
Voltage 
dependent 
Na+ 
channels 
Shorten the AP 
duration and 
decrease the 
initial 
depolarizing 
phase of the AP
Cardiac 
arrest 
10.7 g/kg 
i.p.; 12.5 
g/kg s.c.; 
532 g/kg 
i.g. 
Mebs & 
Hucho, 
1990; Xu et 
al., 2003 
Saxitoxin Marine 
dinoflagellates 
(Alexandrium sp., 
Gymnodinium sp.) 
and cyanobacteria 
(Anabaena sp., 
some 
Aphanizomenon 
spp., 
Cylindrospermopsis 
sp.) 
Heterocy-
clic 
guanidine 
Voltage-
gated Na+ 
channels- 
block 
L-type Ca2+ 
channels- 
partial block
Shorten the AP 
duration and 
decrease the 
initial 
depolarizing 
phase of the AP
Prolongation 
of P-Q 
interval, first 
degree of 
atrio-
ventricular 
block, 
ventricular 
fibrilation 
3 – 10 
µg/kg i.p. 
Anderson, 
2000; Su et 
al., 2003 
Table 3. Natural cardiotoxic toxins from microbes: source, structure, receptors, mode of 
action, effects on heart and toxicity; i.g.- intra-gastric administration 
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electrical activity is blocked leading to blockade of myocardium excitability and cardiac 
arrest, although sodium channels are usually not affected in case of intoxication. 
3.3.2 Algal toxins affecting heart physiology 
Algae are ubiquitous micro-organisms in aqueous environments. Some of them will 
periodically form harmful “blooms.” Karenia brevis is a dinoflagellate that can form harmful 
blooms known as “Florida red tides”. Blooms are associated with the production of a group 
of powerful neurotoxins known as brevetoxins.  
3.3.2.1 Brevetoxins 
Brevetoxin (PbTx) is produced by marine dinoflagellates. It is polyether neurotoxin that 
targets the voltage-gated sodium channels present in all excitable membranes including 
heart tissues. Brevetoxins open voltage-gated sodium ion channels in cell membranes and 
cause uncontrolled sodium influx into the cell leading to the depolarization (Purkerson et 
al., 1999). Humans can be exposed to PbTx by ingesting brevetoxin-contaminated shellfish 
or through other environmental exposures. Its affinity for the rat heart tissue is much lower 
in contrast to the heart tissue of marine animals, but comparable with the skeletal muscle 
and brain (Dechraoui et al., 2006). At least 10 different brevetoxins have been isolated from 
seawater blooms and K. brevis cultures. PbTx in a dose higher than 25 µg/kg produces heart 
block, ventricular extrasystoles and idioventricular rhythms in conscious rats. It was 
concluded that brevetoxin causes changes in the cardiac conduction system and multiple 
changes in the function of the nervous system (Templeton et al., 1989). Systemic 
accumulation of the toxin in artificially respirated cats injected with PbTx leads to 
cardiovascular collapse and death (Borison et al., 1985). 
3.3.2.2 Yessotoxins 
Yessotoxins (YTXs) are polycyclic ether compounds produced by phytoplanktonic 
dinoflagellates (algal toxins). They can accumulate in shellfish which are a source of human 
intoxication through contaminated seafood ingestion. YTX, homoyessotoxin and 45-hydroxy-
homoyessotoxin are lethal when administered intraperitonealy (i.p.) to mice. Although the 
mechanisms of the cardiotoxicity of YTX and homoyessotoxins are not well understood, some 
data from in vitro experiments, such as changes of intracellular calcium and cyclic AMP 
concentrations, alteration of cytoskeletal and adhesion molecules, caspases activation and 
opening of the permeability transition pore of mitochondria, support their cardiotoxic action 
(Dominguez et al., 2010; for a review see Tubaro et al., 2010). They induce microscopically 
visible ultrastructural changes in heart tissue after intraperitoneal and oral exposure. 
Noticeable intracytoplasmic oedema of cardiac muscle cells was observed within three hours 
after the i.p. administration of YTX at a dose of 300 g/kg or higher (Terao et al., 1990). In mice 
YTX produces swelling of cardiomyocytes and separation of organelles in the area near 
capillaries after oral (10 mg/kg) and i.p. (1 mg/kg) toxin administration (Aune et al., 2002). 
3.3.2.3 Ciguatoxin 
Ciguatera caused by fish poisoning is a foodborne disease caused by eating certain fishes 
whose meat is contaminated with ciguatoxins produced by dinoflagellates such as 
Gambierdiscus toxicus. These toxins include ciguatoxin (CTX), maitotoxin, scaritoxin and 
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palytoxin. Ciguatera fish poisoning is primarily endemic in tropical regions of the world. On 
neuroblastoma cells, CTX induces a membrane depolarization which is due to an action that 
increases Na+ permeability and is prevented by voltage-gated sodium channel blocker TTX 
(Bidard et al., 1984). Intravenous injections of ciguatoxin evoke dose-dependent effects: 
bradycardia and atrioventricular conduction block at low doses, ventricular tachycardia at 
sublethal doses, and heart failure at high doses (up to 160 µg/kg) (Legrand et al., 1982). The 
Caribbean ciguatoxin (C-CTX-1) stimulates the release of acetylcholin (ACh) and produces 
muscarinic effect on frog atrial fibres (Sauviat, 1999; Sauviat et al., 2002). 
 
Name Source 
(produced by) 
Chemical 
structure 
Target Mode of 
action 
Effects Acute 
LD50 in 
mice 
Reference 
Algal toxins 
Brevetoxin Dinoflagellate 
Karenia brevis 
 
Cyclic 
polyether 
 
Voltage-
gated 
Na+ 
channels 
Depolari-
zation, AP 
duration 
increase 
Heart block, 
ventricular 
extrasystoles and 
idioventricular 
rhythms 
250 
µg/kg 
i.p. 
Purkerson 
et al., 1999; 
Templeton  
et al., 1989; 
Selwood et 
al., 2008 
Yes-
sotoxins 
Algae Polycyclic 
ether 
compo-
unds 
Voltage 
gated 
Ca2+ 
channels 
Reduction of 
the firing and 
biting 
frequency of 
rat cardiac 
cells 
Changes of 
intracellular Ca2+ 
and cyclic AMP 
concentrations, 
alteration of 
cytoskeletal and 
adhesion 
molecules, 
caspases 
activation and 
opening of the 
permeability 
transition pore of 
mitochondria 
444-512 
µg/kg 
i.p. 
Tubaro et 
al., 2003; 
Dell’Ovo et 
al., 2008 
Ciguatoxin  Dinoflagellate 
Gambierdiscus 
toxicus  
Polyether 
toxins  
Voltage-
gated 
Na+ 
channels 
Depolari-
zation, AP 
duration 
increase, 
arrhythmias 
Biphasic 
inotropic and 
chronotropic 
excitatory, and 
inhibitory effects
0.3 – 10 
µg/kg 
i.p. 
Dechraoui 
et al., 1999 
Maitotoxin Dinoflagellate 
Gambierdiscus 
toxicus 
N/A Ca2+ 
channels 
Agonist AP amplitude 
increase 
0.17 
mg/kg 
i.p. 
Igarashi et 
al., 1999; 
Mebs & 
Hucho, 
1990 
Table 4. Natural cardiotoxic toxins from algae: source, structure, receptors, mode of action, 
effects on heart and toxicity. (N/A - not applicable). 
3.3.2.4 Maitotoxin 
Maitotoxin (MTX) plays an important role in the syndrome named ciguatera poisoning. The 
toxin is derived from Gambierdiscus toxicus, a marine dinoflagellate species (for a review see 
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Mebs & Hucho, 1990). MTX causes dose-dependent effects on the heart. It has positive 
inotropic effects on heart preparations and causes irreversible contracture of isolated rat 
cardiomyocytes that can be prevented by specific voltage-dependent Ca2+ channel blocker 
verapamil (Kobayashi et al., 1986). MTX increases dose-dependent increase in Ca2+ activity 
in freshly dispersed cardiomyocytes. This effect of MTX may be inhibited by reducing Ca2+ 
concentration in the culture medium or by the calcium-channel blocker verapamil. 
Therefore, it has been concluded that MTX specifically activates voltage-dependent Ca2+ 
channels. This influx of Ca2+ into the cells is considered an important mechanism for 
cardiotoxicity of the MTX (Santostasi et al., 1990). 
4. Biologically active molecules from animals affecting heart physiology 
Animal venoms are usually a complex mixture of polypeptides, enzymes and molecules 
which can cause cell injury. Polypeptides exert their effect through action on ion channels 
and in a cell's plasma membrane. Enzymes can cause membrane lysis, pore formation, etc.  
4.1 Palytoxin 
Palytoxin (PTX) was first toxin isolated from the soft coral Palythoa toxica. PTX is one of the 
most powerful marine biotoxins of a high molecular weight ( 3.3 kDa). It is the most potent 
non-proteinic and non-peptidic toxic substance known, with a lethal dose LD50 of 0.15 
g/kg in mice by the i.v. route (Moore & Scheuer, 1971). 
4.2 Iberiotoxin 
Iberiotoxin (IbTX) is derived from the venom of Eastern Indian red scorpion Buthus tamulus. 
IbTX selectively inhibits current through the calcium-activated potassium channels. IbTX in 
a 2 M concentration increased the stimulation-induced ACh release (Kawada et al., 2010). It 
was reported that some patients who had been stung by a scorpion had signs such as 
hypertension and supraventricular tachycardia (Bawaskar & Bawaskar, 1992), to which may 
contribute also IbTX.  
4.3 Batrachotoxins 
Batrachotoxins (BTXs) are neurotoxic steroidal alkaloids first isolated from a Colombian 
poison-dart frog. BTXs are lipid-soluble toxins that bind with a high affinity to the type 2 
receptor site of voltage-gated sodium channels in nerve and muscle membranes, keeping 
them in an open state (Albuquerque et al., 1971; Huang et al., 1984). This results in cell 
depolarization since BTXs inhibit inactivation of sodium channels. BTXs seem to play the 
most important role in cardiotoxicity. The cardiotoxic effects of BTXs accompanied by 
arrhythmia and cardiac arrest are connected to the activation of voltage-gated sodium 
channels in cardiac cells (Mebs & Hucho, 1990). It can evoke premature heart beat and fatal 
ventricular fibrillation associated with the haemodynamic arrest (Albuquerque et al., 1971). 
4.4 Atrotoxin 
Atrotoxin (ATX) is isolated from a venomous rattlesnake species Crotalus atrox found in the 
United States and Mexico. ATX binds reversibly to the voltage-gated calcium channels, 
www.intechopen.com
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leading to the increase of voltage-dependent calcium currents in single, dispersed guinea 
pig ventricular cells. ATX acts as a specific Ca2+ channel agonist (Hamilton et al., 1985). 
4.5 Equinatoxins 
Equinatoxins are pore-forming proteins isolated from the sea anemone Actinia equine. First 
evidence that equinatoxins are cardiotoxic was provided by Sket et al. (1974) by 
administration of tentacle extract of sea anemone i.v. into rats. Later, the isolation of three 
cardiotoxic proteins named Equinatoxin I, II and III with median lethal doses of 23, 35 and 
83 µg/kg in mice, respectively (Macek & Lebez, 1988), was reported. EqT II is a pore 
forming toxin that through de novo formed pores evokes significant increase of intracellular 
Ca2+ activity, which cannot be blocked by conventional sodium and calcium channel 
blockers and probably plays an important role in direct (cytotoxic) or indirect cardiotoxicity 
through coronary vessel contraction and drop of the coronary perfusion rate (Frangež et al., 
2000; Frangež et al., 2008; Zorec et al., 1990). All three equinatoxins are highly haemolytic 
and can cause a dose-dependent increase in potassium activity in blood plasma, leading to 
arrhythmias and cardiac arrest. Administered i.v. they produce dose-dependent 
disturbances in electrical activity of the heart accompanied by blood pressure changes. 
Additional information about direct dose-dependent cardiotoxic effects of EQT IIs were 
provided from the experiments on Langendorff's heart preparations. It causes a 
concentration-dependent drop of the perfusion rate, decreases left ventricular pressure and 
produces arrhythmias followed by cardiac arrest (Bunc et al., 1999). 
4.6 Cardiotoxic-cytotoxic protein from cobra Naja kaouthia 
A cytolytic protein was isolated from the Indian monocellate cobra (Naja kaouthia) venom. 
Intraperitoneal median lethal dose was estimated to be 2.5 mg/kg in Balb/C in male mice. 
In vitro the toxin produces auricular blockade as shown on isolated guinea pig auricle 
(Debnath et al., 2010).  
4.7 Taicatoxin 
Taicatoxin (TCX) is a snake toxin derived from the Australian taipan snake Oxyuranus 
scutellatus scutellatus. TCX reversibly and specifically blocks voltage-dependent L-type 
calcium channels in nanomolar concentrations (Brown et al., 1987). TCX decreases the 
plateau of AP in cardiomyocytes leading to a decrease in contractility. TCX has a negative 
chronotropic effect and evokes arrhythmias (Fantini et al., 1996). Electrocardiographic 
abnormalities were described in patients envenomed with a number of different species 
including Oxyuranus spp. Electrocardiographic changes include septal T wave inversion and 
bradycardia, and atrioventricular block. One of possible mechanisms which might be 
responsible for such clinical signs is a calcium channel blockade on cardiomyocytes (Lalloo 
et al., 1997).  
4.8 Conotoxins  
Conotoxins are peptides derived from the marine snail Conus geographus and consist of 10 to 
30 amino acid residues. Many of these peptides modulate the activity of different ion 
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channels. ω-conotoxin inhibits N-type voltage-dependent Ca2+ channels. It decreases the 
magnitude of cardiac AP and possesses a negative inotropic effect (Nielsen, 2000).  
4.9 Crotoxin 
Crotoxin (CTX) is derived from the venom of the South American rattlesnake, Crotalus 
durissus terrificus. In vitro, CTX decreases contractile force, increases the P-R interval and 
displaces the S-T segment. Arrhythmias are uncommon. The reduction of the contractile 
force and the increase in creatine kinase (CK) activity are ascribed to the release of free fatty 
acids and lysophospholipids, and to a cellular lesion (Santos et al., 1990; Zhang et al., 2010).  
4.10 Sarafotoxin and bibrotoxin 
Sarafotoxins (SRTs) and bibrotoxins are a group of extremely poisonous cardiotoxic snake 
venom peptides that show a striking structural similarity to endothelins (Becker et al., 1993; 
Kloog et al., 1988). SRTs are highly lethal peptides: in mice, the LD50 is 15 µg/kg body 
weight equalling the LD50 for endothelin (Bdolah et al., 1989), which is quite surprising for a 
peptide naturally occurring in the plasma of healthy humans. Sarafotoxin S6C, the most 
acidic endothelin-like peptide, shows reduced vasoconstrictive potency and is a highly 
selective natural ETBR agonist (over 100 000 times higher affinity for the ETBR vs. the ETAR; 
[Williams et al., 1991]).  
4.11 Anti-arrhytmic toxin from tarantula Grammostola spatulata 
Gs-Mtx-4 is an amfipathic peptide toxin derived from the venom of the tarantula spider 
(Grammostola spatulata) with a molecular weight of 4 kDa (Hodgson & Isbister, 2009). It is the 
only toxin known that specifically affects cationic stretch activated ion channels and is 
therefore able to inhibit atrial fibrillation (Bowman et al., 2007).  
5. Natural toxins as drugs 
Some of the natural toxins acting on the cardiovascular system are very potent and highly 
specific for some receptors in cardiac and neuronal tissue. They can block, activate and even 
modulate the ion channels activity in excitable membranes. Although they are very stable 
molecules and possess high receptors specificity, they are seldom used as therapeutic drugs. 
Information about their three dimensional structure and data from structure-function 
studies of protein toxins may provide useful information for synthesis of smaller analogues 
with lower toxicity. Few natural toxins have potential in clinical use for treatment of 
cardiovascular dysfunction. Some of them have a positive inotropic effect, i.e. grayanotoxin, 
veratridine (Brill & Wasserstrom, 1986; Tirapelli et al., 2008). Due to their high toxicity, none 
of the described natural cardiotoxic substances are used as therapeutic drugs for treating 
cardiovascular diseases. Recently, sarafotoxins have been utilized to develop new, low 
molecular weight substances with metalloproteinase inhibitory activity. The modified 
molecule of the sarafotoxin 6b is used as a starting point, which has retained 
metalloproteinase inhibitory activity and removed vasoconstrictor activity. From this, the 
peptide (STX-S4-CT) was developed, which will hopefully provide a foundation for further 
development of improved candidate molecules (Hodgson & Isbister, 2009). Some promising  
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Name Source 
(produced by)
Chemical 
structure 
Target Mode of 
action 
Effects Acute LD50 
in mice 
Source 
Animal toxins 
Palytoxin Soft coral: 
Palythoa toxica
Aliphatics 
carbon chain 
containing a 
series of 
heterocyclic 
rings 
Na+/K+-
ATPase; 
Hemolysin  
Voltage-
dependent K+ 
channels 
Haemolysis, 
arrhythmias 
0.15 µg/kg Sosa et al., 
2009 
Equinatoxin I, 
II, II 
Sea anemone: 
Actinia equina
Proteins Haemolysin New cation 
non-selective 
pore 
formation 
Dose-dependent 
arrhythmias, 
cardiac arrest, 
haemolysis 
25,30 and 
83 µg/kg 
i.v. 
Maček & 
Lebez, 1988; 
Sket et al., 
1974 
Batrachotoxins 
(BTX) 
Some frogs 
species 
(poison-dart 
frog), melyrid 
beetles and 
birds (Ifrita 
kowaldi, 
Colluricincla 
megarhyncha) 
Steroidal 
alkaloids 
Na+ 
channels 
Depolarize, 
lengthen the 
AP 
Arrhythmias, 
extrasystoles, 
ventricular 
fibrillation 
2 µg/kg 
s.c. 
Albuquerque 
et al., 1971; 
Mebs & 
Hucho, 1990 
Atrotoxin Snake: 
Crotalus atrox 
N/A Ca2+ 
channels 
Agonist, AP 
amplitude 
increase 
Arrhythmias 89.4 – 137 
µg i.v. 
Hamilton et 
al., 1985; 
Barros et al., 
1998 
Cardiotoxic-
cytotoxic 
protein (MW 
6.76 kDa) 
Indian 
monocellate 
cobra (Naja 
kaouthia) 
Protein Heart Sinuauricular 
blockade 
Arrhythmias 2.5 mg/kg 
i.p. 
Debnath  et 
al., 2010 
Taicatoxin 
(TCX) 
Australian 
taipan snake 
Oxyuranus 
scutellatus 
N/A Ca2+ 
channels 
Antagonist Bradycardia, 
atrioventricular 
block  
N/A Brown et al., 
1987; Lalloo et 
al., 1997 
Omega-
conotoxin 
Cone snail 
from genus 
Conus 
Peptide N-type 
voltage-
dependent 
Ca2+ 
channels  
Antagonist Decreases the 
magnitude of 
AP plateau, 
negative 
inotropic effects
N/A Nielsen, 2000 
Crotoxin 
(CTX) 
South 
American 
rattlesnake 
(Crotalus 
durissus 
terrificus) 
Protein; 
crotapotin 
basic 
phospolipase 
A2 
L-type Ca2+ 
channels 
Agonist Elongation of 
AP duration, an 
increase of its 
amplitude 
55.5 – 70.5 
µg/kg i.p. 
Rangel-Santos 
et al., 2004 
Sarafotoxin 
(SRTs) and 
bibrotoxin 
Snake: 
Atractaspis 
engaddensis 
Peptide Endothelin 
receptors 
Agonist Arrhythmias 15 µg/kg Bdolah et al., 
1989 
GsMtx-4 Spider – 
tarantula: 
Grammostola 
spatulata 
Peptide Stretch 
activated ion 
channels 
(SACs) 
Antagonist  Inhibits atrial 
fibrillation 
N/A Bowman et al., 
2007 
 
 
Table 5. Natural cardiotoxic toxins from animals: source, structure, receptors, mode of 
action, effects on heart and toxicity. (N/A - not applicable). 
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results in the treatment of cardiovascular disorders were also obtained with GsMtx-4 toxin 
isolated from tarantula Grammostola spatulata venom. This toxin is able to inhibit the stretch 
activated ion channels (SACs) and consequently inhibits atrial fibrillation. Due to its 
described properties, it can be used as a framework for developing a new class of anti-
arrhythmic drugs, which would be directed against pathophysiologic mechanisms of atrial 
fibrillation, instead of just dealing with the symptoms as with many current therapies 
(Hodgson & Isbister, 2009). 
6. Conclusion 
Severe acute toxic insult caused by natural toxins can cause functional changes in heart 
tissue physiology or even cardiac cell death. Most of the natural toxins derived from plants, 
bacteria, phytoplanktonic dinoflagellates, fungi and animals target ionic channels in 
excitable membranes of cardiac cells or cardiac cell membranes itself, produce alteration in 
AP (e.g. depolarization, repolarization, alterations in its duration) or significant changes in 
intracellular ion activity. These changes may lead to reversible or even irreversible life 
threatening cardiac arrhythmias and eventually heart failure. 
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cardiovascular risk factors or history of heart disease. Early detection of the patients proneness for developing
cardiotoxicity is the key issue to decrease morbidity and mortality. It also facilitates more tailored therapeutic
interventions. Therefore, the collaboration and interaction of cardiology and oncology may contribute to
reducing the cardiovascular adverse effects and improving the results in the treatment of patients with cancer.
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